Price Transparency Is Here. Two Communication Actions to Take

The CMS price transparency mandate is in effect at long last, after a yearlong delay, court challenges, worries over confused patients, concerns about disclosing proprietary data, and COVID-19-related setbacks.

Uncontextualized chargemaster data and prices might constitute bare-bones compliance with the mandate, but an organization's price transparency work shouldn't end there. Industry leaders agree more is needed to achieve true price transparency success.

HealthLeaders talks to healthcare leaders and industry experts about ramping up communication efforts around two areas to make price transparency useful for patients and healthcare organizations.